Evidence map›Paper›PMID 20374433›Full record

ArticleJournal of neurochemistry2010

Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors.

Do Young Kim, Johana Vallejo, Jong M Rho

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Neuroglia and brain energy metabolism.Handbook of clinical neurology · 2025
    Review
  7. Article
  8. Review
  9. Frontiers in neuroscience · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. The metabolic basis of epilepsy.Nature reviews. Neurology · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Non-pharmacological Interventions for Intractable Epilepsy.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Do Young KimBarrow Neurological Institute and St. Joseph's Hospital & Medical Center, Phoenix, Arizona 85013, USA. doyoung.kim@chw.edu
Johana Vallejo
Jong M Rho
Barrow Neurological Institute · USMidwestern University · US

Funding

GABAergic Inhibition and the Ketogenic DietK02NS044846 · NINDS · UNIVERSITY OF CALIFORNIA IRVINE · PI RHO, JONG MIN · 2003 to 2007
$619k
NINDS NIH HHS K02 NS044846NINDS NIH HHS NS044846
6 · The paper itself

Abstract

Ketones have previously shown beneficial effects in models of neurodegenerative disorders, particularly against associated mitochondrial dysfunction and cognitive impairment. However, evidence of a synaptic protective effect of ketones remains lacking. We tested the effects of ketones on synaptic impairment induced by mitochondrial respiratory complex (MRC) inhibitors using electrophysiological, reactive oxygen species (ROS) imaging and biochemical techniques. MRC inhibitors dose-dependently suppressed both population spike (PS) and field potential amplitudes in the CA1 hippocampus. Pre-treatment with ketones strongly prevented changes in the PS, whereas partial protection was seen in the field potential. Rotenone (Rot; 100 nmol/L), a MRC I inhibitor, suppressed synaptic function without altering ROS levels and PS depression by Rot was unaffected by antioxidants. In contrast, antioxidant-induced PS recovery against the MRC II inhibitor 3-nitropropionic acid (3-NP; 1 mmol/L) was similar to the synaptic protective effects of ketones. Ketones also suppressed ROS generation induced by 3-NP. Finally, ketones reversed the decreases in ATP levels caused by Rot and 3-NP. In summary, our data demonstrate that ketones can preserve synaptic function in CA1 hippocampus induced by MRC dysfunction, likely through an antioxidant action and enhanced ATP generation.

Indexed as

3-Hydroxybutyric AcidAcetoacetatesAction PotentialsAdenosine TriphosphateAnimalsCA1 Region, HippocampalCatalaseElectron Transport Chain Complex ProteinsHydrogen PeroxideIn Vitro TechniquesKetonesNeuroprotective AgentsNitro CompoundsPropionatesRatsRats, Sprague-Dawley3-Hydroxybutyric Acid3-nitropropionic acidAcetoacetatesacetoacetic acidAdenosine TriphosphateCatalaseElectron Transport Chain Complex ProteinsHydrogen PeroxideKetonesNeuroprotective AgentsNitro CompoundsPropionatesReactive Oxygen SpeciesRotenone

Identifiers

PMID20374433
PMCPMC3532617
OpenAlexW1609188888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.